Opendoor stock jumps on Trump’s $200 billion mortgage bond plan; what investors watch next

Opendoor stock jumps on Trump’s $200 billion mortgage bond plan; what investors watch next

New York, January 10, 2026, 18:39 EST — Market closed

  • Opendoor shares jumped roughly 13% on Friday amid a rally in housing-related stocks sparked by a fresh push to buy mortgage bonds.
  • Treasury Secretary Scott Bessent said the move aims to counter the Fed’s monthly mortgage bond runoff.
  • Next week’s U.S. inflation numbers and any new updates on bond purchase speeds are on traders’ radar.

Opendoor Technologies Inc shares jumped 13.2% on Friday, closing at $7.29. The rally followed President Donald Trump’s directive to buy $200 billion in mortgage bonds aimed at lowering borrowing costs. The stock swung between $6.82 and $7.91, with roughly 167 million shares changing hands.

This matters now since Opendoor’s business depends on housing turnover, which has been hit hard by soaring mortgage rates. Investors are quick to jump on anything hinting at rate cuts, often before the specifics are clear.

Opendoor uses an “iBuyer” model, snapping up homes directly to flip them. That means funding costs and price jumps hit hard and fast. Even a slight move in mortgage rates can swiftly shift demand.

Trump said he is directing his team to buy $200 billion in mortgage bonds, pitching the move as a way to lower mortgage rates and monthly payments. Federal Housing Finance Agency Director Bill Pulte confirmed that Fannie Mae and Freddie Mac would handle the purchases but refused to provide a timeline or reveal future plans. Redfin’s chief economist, Chen Zhao, cautioned the effect could be “fairly small,” estimating a 10 to 15 basis point impact — with a basis point equal to 0.01%. (Reuters)

Treasury Secretary Scott Bessent told Reuters the goal is to roughly keep pace with the Federal Reserve’s mortgage-backed securities roll-off, which runs around $15 billion monthly. The FHFA kicked off with $3 billion in initial purchases. Bessent noted these buybacks probably won’t lower mortgage rates directly but could tighten the yield spread—the difference between mortgage bond yields and Treasuries—potentially easing consumer mortgage costs. (Reuters)

Housing-sensitive stocks followed Opendoor higher. loanDepot jumped sharply, with Rocket Companies and UWM Holdings also climbing as homebuilders gained ground. TD Cowen noted this move might tighten the gap between the 30-year mortgage rate and the 10-year Treasury yield. Brian Jacobsen, chief economic strategist at Annex Wealth Management, cautioned that “every little bit will help” on yields but stressed the policy may boost demand without resolving supply issues. (Reuters)

Opendoor enters the new week with shares holding far below their 52-week peak of $10.87, despite a recent rebound from a low of $0.51, according to Public.com data. The company’s market cap stands near $7 billion, and Friday’s trading volume surged past the usual average of about 101 million shares. (Public)

From a technical standpoint, traders are eyeing Friday’s low around $6.80 as a short-term floor, with the $7.90 level marking the initial resistance where the rally ran out of steam. If policy news continues to support housing stocks, Opendoor remains a ticker prone to sharp moves on either side.

The setup works both ways. If mortgage rates don’t drop as expected—or if bond purchases slow or fall short—the rally could stall quickly. Plus, cheaper financing might spur demand, driving prices up and doing little to improve affordability, leaving deals stuck in limbo.

The next big macro event hits Tuesday with the U.S. Labor Department’s release of the Consumer Price Index for December 2025. A surprise there could jolt Treasury yields—and quickly ripple into rate-sensitive housing stocks. (Bureau of Labor Statistics)

Nasdaq pins Opendoor’s earnings release for Feb. 26. Investors will zero in on inventory figures, unit economics, and how the company’s leadership addresses the interest rate environment as spring approaches. (Nasdaq)

Stock Market Today

  • Ipsen Partners with Origami to Expand Rare Disease Pipeline; Shares Seen as Undervalued
    February 1, 2026, 1:59 AM EST. Ipsen (ENXTPA:IPN) announced a global collaboration and option agreement with Origami Therapeutics to develop a novel small molecule for a rare neurodegenerative disorder. This move aligns with Ipsen's focus on rare diseases and neuroscience, aiming to deliver first or best in class therapies. Shares are currently trading about 3.7% above the €132.73 consensus target but flagged as 30.8% undervalued by Simply Wall St's analysis. The stock shows strong short-term momentum with an 18.5% 30-day return. Key risks include execution challenges and reduced profit margins, which fell to 11.9% from 19.3% last year. Investors should monitor clinical milestones and valuation shifts as the program progresses.
Rocket Companies stock (RKT) jumps on Trump’s $200B mortgage-bond move — what to watch next
Previous Story

Rocket Companies stock (RKT) jumps on Trump’s $200B mortgage-bond move — what to watch next

BigBear.ai stock in focus after Patriots-Kraft deal as note conversion deadline nears
Next Story

BigBear.ai stock in focus after Patriots-Kraft deal as note conversion deadline nears

Go toTop